<?xml version='1.0' encoding='utf-8'?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-us"><title>Docket updates for IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://michaellee50.github.io/CourtListener/feed-MDL-No.-3094.xml" rel="self" type="application/atom+xml" /><link href="https://www.courtlistener.com/" rel="alternate" /><link href="https://www.courtlistener.com/docket/68082231/feed/" rel="self" /><id>https://www.courtlistener.com/</id><updated>2025-08-28T00:00:00-07:00</updated><author><name>Free Law Project</name><email>feeds@courtlistener.com</email></author><rights>Created for the public domain by Free Law Project</rights><entry><title>Entry #312 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-312" rel="alternate" /><published>2025-08-28T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-312</id><summary type="html">CONDITIONAL TRANSFER ORDER FINALIZED (CTO-30) - 3 action(s) re: pldg. (1 in DE/1:25-cv-01042, 309 in MDL No. 3094, 1 in NJ/3:25-cv-14603, 1 in NJ/3:25-cv-14605) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 8/28/2025. Associated Cases: MDL No. 3094, DE/1:25-cv-01042, NJ/3:25-cv-14603, NJ/3:25-cv-14605 (LH) (Entered: 08/28/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001508668?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-28T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-08-27 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-08-27T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596773</id><summary type="html">XYZ CASES ENTERED -- 1 related action(s) originating in the transferee district. JPML notified on 8/14/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-04685) (LH)</summary><updated>2025-08-27T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-08-27 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-08-27T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596772</id><summary type="html">XYZ CASES ENTERED -- 46 related action(s) originating in the transferee district. JPML notified on 8/13/2025 to 8/15/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-04630,2:25-cv-04634,2:25-cv-04635,2:25-cv-04636,2:25-cv-04637,2:25-cv-04639, 2:25-cv-04642,2:25-cv-04641,2:25-cv-04645,2:25-cv-04646,2:25-cv-04647,2:25-cv-04648, 2:25-cv-04581,2:25-cv-04595,2:25-cv-04651,2:25-cv-04650,2:25-cv-04653,2:25-cv-04654, 2:25-cv-04657,2:25-cv-04681,2:25-cv-04680,2:25-cv-04679,2:25-cv-04677,2:25-cv-04674, 2:25-cv-04673,2:25-cv-04672,2:25-cv-04671,2:25-cv-04670,2:25-cv-04684,2:25-cv-04655, 2:25-cv-04656,2:25-cv-04692,2:25-cv-04690,2:25-cv-04696,2:25-cv-04695,2:25-cv-04687, 2:25-cv-04688,2:25-cv-04689,2:25-cv-04697,2:25-cv-04706,2:25-cv-04709,2:25-cv-04715, 2:25-cv-04720,2:25-cv-04722,2:25-cv-04723,2:25-cv-04725) (LH) Modified on 8/27/2025 (LH).</summary><updated>2025-08-27T00:00:00-07:00</updated></entry><entry><title>Entry #311 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-311" rel="alternate" /><published>2025-08-25T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-311</id><summary type="html">CONDITIONAL TRANSFER ORDER FINALIZED (CTO-29) - 1 action(s) re: pldg. ( 304 in MDL No. 3094, 1 in NJ/2:25-cv-14454) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 8/25/2025. Associated Cases: MDL No. 3094, NJ/2:25-cv-14454 (TO) (Entered: 08/25/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001508151?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-25T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-08-20 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-08-20T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596770</id><summary type="html">XYZ CASES ENTERED -- 1 related action(s) originating in the transferee district. JPML notified on 8/13/2025 via e-mail. -- Pennsylvania Eastern District Court (2:24-cv-01286) (LH)</summary><updated>2025-08-20T00:00:00-07:00</updated></entry><entry><title>Entry #310 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-310" rel="alternate" /><published>2025-08-20T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-310</id><summary type="html">***TEXT ONLY NOTICE******A PROOF OF SERVICE IS REQUIRED FOR ALL FILINGS***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-30) re: pldg. (1 in DE/1:25-cv-01042, 309 in MDL No. 3094, 1 in NJ/3:25-cv-14603, 1 in NJ/3:25-cv-14605) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 8/27/2025.Attorneys must be registered to file in the JPML. Please visit our website for Registration Information. Signed by Clerk of the Panel James V. Ingold on 8/20/2025. Associated Cases: MDL No. 3094, DE/1:25-cv-01042, NJ/3:25-cv-14603, NJ/3:25-cv-14605 (LH) (Entered: 08/20/2025)</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?310,1674416,,," length="0" rel="enclosure" /><updated>2025-08-20T00:00:00-07:00</updated></entry><entry><title>Entry #309 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-309" rel="alternate" /><published>2025-08-20T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-309</id><summary type="html">CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-30) - 3 action(s) Signed by Clerk of the Panel James V. Ingold on 8/20/2025. Associated Cases: MDL No. 3094, DE/1:25-cv-01042, NJ/3:25-cv-14603, NJ/3:25-cv-14605 (LH) (Entered: 08/20/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001507566?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-20T00:00:00-07:00</updated></entry><entry><title>Entry #308 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-308" rel="alternate" /><published>2025-08-20T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-308</id><summary type="html">CONDITIONAL TRANSFER ORDER FINALIZED (CTO-28) - 1 action(s) re: pldg. ( 304 in MDL No. 3094) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 8/20/2025. Associated Cases: MDL No. 3094, CAC/2:25-cv-07324 (LH) (Entered: 08/20/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001507500?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-20T00:00:00-07:00</updated></entry><entry><title>Entry #307 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-307" rel="alternate" /><published>2025-08-19T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-307</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 1 Action(s) -- Filed by attorney Diana M. Watral, counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- Delaware District Court (1:25-cv-01042) (Attachments: # 1 Schedule of Actions, # 2 Proof of Service, # 3 Complaint DE 1:25-cv-01042) (Watral, Diana) (Entered: 08/19/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001507410?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-19T00:00:00-07:00</updated></entry><entry><title>Entry #306 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-306" rel="alternate" /><published>2025-08-18T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-306</id><summary type="html">CONDITIONAL TRANSFER ORDER FINALIZED (CTO-27) - 2 action(s) re: pldg. (2 in INS/1:25-cv-01532, 2 in INS/1:25-cv-01539, 297 in MDL No. 3094) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 8/18/2025. Associated Cases: MDL No. 3094, INS/1:25-cv-01532, INS/1:25-cv-01539 (LH) (Entered: 08/18/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001506971?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-18T00:00:00-07:00</updated></entry><entry><title>Entry #305 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-305" rel="alternate" /><published>2025-08-15T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-305</id><summary type="html">***TEXT ONLY NOTICE******A PROOF OF SERVICE IS REQUIRED FOR ALL FILINGS***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-29) re: pldg. ( 304 in MDL No. 3094, 1 in NJ/2:25-cv-14454) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 8/22/2025.Attorneys must be registered to file in the JPML. Please visit our website for Registration Information. Signed by Clerk of the Panel James V. Ingold on 8/15/2025. Associated Cases: MDL No. 3094, NJ/2:25-cv-14454 (LH) (Entered: 08/15/2025)</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?305,1674416,,," length="0" rel="enclosure" /><updated>2025-08-15T00:00:00-07:00</updated></entry><entry><title>Entry #304 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-304" rel="alternate" /><published>2025-08-15T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-304</id><summary type="html">CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-29) - 1 action(s) Signed by Clerk of the Panel James V. Ingold on 8/15/2025. Associated Cases: MDL No. 3094, NJ/2:25-cv-14454 (LH) (Entered: 08/15/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001506789?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-15T00:00:00-07:00</updated></entry><entry><title>Entry #303 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-303" rel="alternate" /><published>2025-08-14T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-303</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 2 Action(s) -- Filed by attorney Diana M. Watral, counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- New Jersey District Court (3:25-cv-14603,3:25-cv-14605) (Attachments: # 1 Schedule of Action, # 2 Proof of Service, # 3 Complaint NJ 3:25-cv-14603, # 4 Complaint NJ 3:25-cv-14605) (Watral, Diana) Modified on 8/18/2025 (JW). CHANGED OFFICE NUMBER FROM 2 TO 3. Modified on 8/18/2025 (JW). (Entered: 08/14/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001506585?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-14T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-08-13 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-08-13T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596761</id><summary type="html">XYZ CASES ENTERED -- 2 related action(s) originating in the transferee district. JPML notified on 8/11/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-04562,2:25-cv-04563) (LH)</summary><updated>2025-08-13T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-08-13 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-08-13T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596760</id><summary type="html">XYZ CASES ENTERED -- 46 related action(s) originating in the transferee district. JPML notified on 8/11/2025 to 8/13/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-04531,2:25-cv-04530,2:25-cv-04536,2:25-cv-04537,2:25-cv-04540,2:25-cv-04541, 2:25-cv-03895,2:25-cv-04542,2:25-cv-04544,2:25-cv-04548,2:25-cv-04556,2:25-cv-04554, 2:25-cv-04551,2:25-cv-04558,2:25-cv-04559,2:25-cv-04568,2:25-cv-04569,2:25-cv-04570, 2:25-cv-04571,2:25-cv-04572,2:25-cv-04573,2:25-cv-04574,2:25-cv-04575,2:25-cv-04576, 2:25-cv-04577,2:25-cv-04578,2:25-cv-04579,2:25-cv-04580,2:25-cv-04584,2:25-cv-04592, 2:25-cv-04589,2:25-cv-04586,2:25-cv-04594,2:25-cv-04596,2:25-cv-04598,2:25-cv-04600, 2:25-cv-04601,2:25-cv-04607,2:25-cv-04610,2:25-cv-04613,2:25-cv-04615,2:25-cv-04614, 2:25-cv-04616,2:25-cv-04623,2:25-cv-04625,2:25-cv-04624) (LH)</summary><updated>2025-08-13T00:00:00-07:00</updated></entry><entry><title>Entry #302 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-302" rel="alternate" /><published>2025-08-12T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-302</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 1 Action(s) -- Filed by attorney Diana M. Watral, counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- New Jersey District Court (2:25-cv-14454) (Attachments: # 1 Schedule of Actions, # 2 Proof of Service, # 3 Complaint) (Watral, Diana) (Entered: 08/12/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001505998?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-12T00:00:00-07:00</updated></entry><entry><title>Entry #301 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-301" rel="alternate" /><published>2025-08-12T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-301</id><summary type="html">***TEXT ONLY NOTICE******A PROOF OF SERVICE IS REQUIRED FOR ALL FILINGS***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-28) re: pldg. (2 in CAC/2:25-cv-07324, 300 in MDL No. 3094) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 8/19/2025.Attorneys must be registered to file in the JPML. Please visit our website for Registration Information. Signed by Clerk of the Panel James V. Ingold on 8/12/2025. Associated Cases: MDL No. 3094, CAC/2:25-cv-07324 (LH) (Entered: 08/12/2025)</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?301,1674416,,," length="0" rel="enclosure" /><updated>2025-08-12T00:00:00-07:00</updated></entry><entry><title>Entry #300 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-300" rel="alternate" /><published>2025-08-12T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-300</id><summary type="html">CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-28) - 1 action(s) Signed by Clerk of the Panel James V. Ingold on 8/12/2025. Associated Cases: MDL No. 3094, CAC/2:25-cv-07324 (LH) (Entered: 08/12/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001505906?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-12T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-08-08 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-08-08T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596756</id><summary type="html">XYZ CASES ENTERED -- 18 related action(s) originating in the transferee district. JPML notified on 4/4/2025 to 4/8/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-04439,2:25-cv-04427,2:25-cv-04428,2:25-cv-04429,2:25-cv-04430,2:25-cv-04431, 2:25-cv-04434,2:25-cv-04433,2:25-cv-04436,2:25-cv-04438,2:25-cv-04437,2:25-cv-04441, 2:25-cv-04457,2:25-cv-04460,2:25-cv-04482,2:25-cv-04481,2:25-cv-04499,2:25-cv-04525) (LH)</summary><updated>2025-08-08T00:00:00-07:00</updated></entry><entry><title>Entry #299 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-299" rel="alternate" /><published>2025-08-08T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-299</id><summary type="html">CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( 296 in MDL No. 3094) Filed by Defendant Novo Nordisk Inc. -- Associated Cases: MDL No. 3094, CAC/2:25-cv-07324 (Brown, Loren) (Entered: 08/08/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001505439?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-08T00:00:00-07:00</updated></entry><entry><title>Entry #298 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-298" rel="alternate" /><published>2025-08-08T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-298</id><summary type="html">***TEXT ONLY NOTICE******A PROOF OF SERVICE IS REQUIRED FOR ALL FILINGS***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-27) re: pldg. (2 in INS/1:25-cv-01532, 2 in INS/1:25-cv-01539, 297 in MDL No. 3094) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 8/15/2025.Attorneys must be registered to file in the JPML. Please visit our website for Registration Information. Signed by Clerk of the Panel James V. Ingold on 8/8/2025. Associated Cases: MDL No. 3094, INS/1:25-cv-01532, INS/1:25-cv-01539 (LH) (Entered: 08/08/2025)</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?298,1674416,,," length="0" rel="enclosure" /><updated>2025-08-08T00:00:00-07:00</updated></entry><entry><title>Entry #297 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-297" rel="alternate" /><published>2025-08-08T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-297</id><summary type="html">CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-27) - 2 action(s) Signed by Clerk of the Panel James V. Ingold on 8/8/2025. Associated Cases: MDL No. 3094, INS/1:25-cv-01532, INS/1:25-cv-01539 (LH) (Entered: 08/08/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001505398?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-08T00:00:00-07:00</updated></entry><entry><title>Entry #296 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-296" rel="alternate" /><published>2025-08-07T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-296</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 1 Action(s) -- Filed by attorney Loren H. Brown, counsel for Defendant Novo Nordisk Inc. -- California Central District Court (2:25-cv-07324) (Attachments: # 1 Schedule of Actions, # 2 Proof of Service, # 3 Complaint CAC/2:25-cv-07324) (Brown, Loren) Modified on 8/11/2025 (LH). ADDED PARTY TYPE (Entered: 08/07/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001505315?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-07T00:00:00-07:00</updated></entry><entry><title>Entry #295 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-295" rel="alternate" /><published>2025-08-06T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-295</id><summary type="html">ERRATA - to ( 294 in MDL No. 3094) - Filed by Defendants ELI LILLY AND COMPANY, LILLY USA, LLC (Attachments: # 1 Schedule of Actions, # 2 Proof of Service) Associated Cases: MDL No. 3094, INS/1:25-cv-01532, INS/1:25-cv-01539 (Watral, Diana) (Entered: 08/06/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001504992?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-06T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-08-06 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-08-06T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596750</id><summary type="html">XYZ CASES ENTERED -- 18 related action(s) originating in the transferee district. JPML notified on 7/28/2025 to 8/1/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-04037,2:25-cv-04024,5:25-cv-04139,2:25-cv-04388,2:25-cv-04392,2:25-cv-04409, 2:25-cv-04408,2:25-cv-04404,2:25-cv-04402,2:25-cv-04412,2:25-cv-04414,2:25-cv-04413, 2:25-cv-04401,2:25-cv-04416,2:25-cv-04417,2:25-cv-04419,2:25-cv-04421,2:25-cv-04422) (LH) Modified on 8/7/2025 (LH).</summary><updated>2025-08-06T00:00:00-07:00</updated></entry><entry><title>Entry #294 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-294" rel="alternate" /><published>2025-08-02T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-294</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- Two Action(s) -- Filed by attorney Diana M. Watral, counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- Indiana Southern District Court (1:25-cv-01532,1:25-cv-01539) (Attachments: # 1 Schedule of Actions, # 2 Complaint SDIND 1:25-cv-1532, # 3 Complaint SDIND 1:25-cv-01539, # 4 Proof of Service) (Watral, Diana) (Entered: 08/02/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001504576?caseid=1674416" length="0" rel="enclosure" /><updated>2025-08-02T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-07-30 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-07-30T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596748</id><summary type="html">XYZ CASES ENTERED -- 1 related action(s) originating in the transferee district. JPML notified on 7/25/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-03891) (LH)</summary><updated>2025-07-30T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-07-30 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-07-30T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596747</id><summary type="html">XYZ CASES ENTERED -- 6 related action(s) originating in the transferee district. JPML notified on 7/25/2025 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-03892,2:25-cv-03893,2:25-cv-03894,2:25-cv-03896,2:25-cv-03953,2:25-cv-03886) (LH)</summary><updated>2025-07-30T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-07-25 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-07-25T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596746</id><summary type="html">XYZ CASES ENTERED -- 29 related action(s) originating in the transferee district. JPML notified on 7/25/25 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-03848,2:25-cv-03843,2:25-cv-03849,2:25-cv-03846,2:25-cv-03847,2:25-cv-03811, 2:25-cv-03815,2:25-cv-03819,2:25-cv-03821,2:25-cv-03820,2:25-cv-03827,2:25-cv-03831, 2:25-cv-03834,2:25-cv-03840,2:25-cv-03838,2:25-cv-03871,2:25-cv-03872,2:25-cv-03876, 2:25-cv-03878,2:25-cv-03879,2:25-cv-03884,2:25-cv-03883,2:25-cv-03880,2:25-cv-03881, 2:25-cv-03869,2:25-cv-03868,2:25-cv-03867,2:25-cv-03866,2:25-cv-03890) (JW)</summary><updated>2025-07-25T00:00:00-07:00</updated></entry><entry><title>Minute entry from 2025-07-25 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-07-25T00:00:00-07:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-436596745</id><summary type="html">XYZ CASES ENTERED -- 40 related action(s) originating in the transferee district. JPML notified on 7/21/25-7/25/25 via NEF. -- Pennsylvania Eastern District Court (2:25-cv-03711,2:25-cv-03727,2:25-cv-03728,2:25-cv-03732,2:25-cv-03733,2:25-cv-03743, 2:25-cv-03756,2:25-cv-03757,2:25-cv-03758,2:25-cv-03759,2:25-cv-03761,2:25-cv-03762, 2:25-cv-03763,2:25-cv-03764,2:25-cv-03765,2:25-cv-03766,2:25-cv-03768,2:25-cv-03769, 2:25-cv-03770,2:25-cv-03771,2:25-cv-03772,2:25-cv-03774,2:25-cv-03784,2:25-cv-03791, 2:25-cv-03794,2:25-cv-03795,2:25-cv-03804,2:25-cv-03805,2:25-cv-03806,2:25-cv-03807, 2:25-cv-03865,2:25-cv-03864,2:25-cv-03863,2:25-cv-03861,2:25-cv-03860,2:25-cv-03858, 2:25-cv-03854,2:25-cv-03856,2:25-cv-03851,2:25-cv-03850) (JW)</summary><updated>2025-07-25T00:00:00-07:00</updated></entry></feed>